PUFFEPINEPHRIN Trademark

Trademark Overview

On Friday, February 14, 2020, a trademark application was filed for PUFFEPINEPHRIN with the United States Patent and Trademark Office. The USPTO has given the PUFFEPINEPHRIN trademark a serial number of 88797750. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, December 26, 2023. This trademark is owned by 1232176 B.C. Ltd.. The PUFFEPINEPHRIN trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

inhaled pharmaceutical preparations for the treatment of anaphylaxis and respiratory disorders

inhalers for therapeutic use
puffepinephrin

General Information

Serial Number88797750
Word MarkPUFFEPINEPHRIN
Filing DateFriday, February 14, 2020
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, December 26, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesinhaled pharmaceutical preparations for the treatment of anaphylaxis and respiratory disorders
Goods and Servicesinhalers for therapeutic use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, February 20, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKOKUA PHARMA INC.
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressRICHMOND V7C5L9
CA
Party Name1232176 B.C. Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRichmond, BC V7C5L9
CA

Trademark Events

Event DateEvent Description
Tuesday, May 12, 2020NON-FINAL ACTION WRITTEN
Tuesday, February 18, 2020NEW APPLICATION ENTERED
Thursday, February 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 6, 2020ASSIGNED TO EXAMINER
Tuesday, May 12, 2020NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 6, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 7, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 9, 2020SUSPENSION LETTER WRITTEN
Monday, November 9, 2020LETTER OF SUSPENSION E-MAILED
Monday, November 9, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 11, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, August 16, 2021SUSPENSION INQUIRY WRITTEN
Monday, August 16, 2021INQUIRY TO SUSPENSION E-MAILED
Monday, August 16, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, February 11, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, February 16, 2022ASSIGNED TO LIE
Wednesday, February 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 17, 2022SUSPENSION LETTER WRITTEN
Thursday, February 17, 2022LETTER OF SUSPENSION E-MAILED
Thursday, February 17, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 23, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, August 24, 2022SUSPENSION INQUIRY WRITTEN
Wednesday, August 24, 2022INQUIRY TO SUSPENSION E-MAILED
Wednesday, August 24, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, September 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 29, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 29, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, September 29, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 8, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, February 15, 2023ASSIGNED TO LIE
Thursday, February 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 17, 2023SUSPENSION LETTER WRITTEN
Friday, February 17, 2023LETTER OF SUSPENSION E-MAILED
Friday, February 17, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 27, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, September 28, 2023SUSPENSION INQUIRY WRITTEN
Thursday, September 28, 2023INQUIRY TO SUSPENSION E-MAILED
Thursday, September 28, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, December 22, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, December 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 26, 2023SUSPENSION LETTER WRITTEN
Tuesday, December 26, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, December 26, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 8, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

puffepinephrin disorders inhalers therapeutic respiratory anaphylaxis pharmaceutical preparations treatment inhaled